HEMATOPOIETIC STEM CELL TRANSPLANTATION AND NEPHROPATHY
https://doi.org/10.24884/1561-6274-2018-22-1-52-57
Abstract
Hematopoietic cell transplantation (HCT) is becoming an increasing common treatment modality for a variety of diseases. Kidneys are recognized as a target organ of acute and chronic graft-versus host disease (GvHD).Glomerulopathy significantly limits patient life-time. Acute kidney injury occurs on average in 100 days after HCT in 15 – 73% of patients due to treatmentrelated toxity and radiation. Chronic GvHD is associated with chronic kidney disease. The majority of CKD after transplantation is idiopathic syndrome, thrombotic microangiopathy and nephrоtic syndrome.
About the Authors
N. B. Kuprienko
Pavlov First Saint Petersburg State Medical University; Almazov National Medical Research Centre
Russian Federation
Russian Federation
Smirnova Natalia N - MD, PhD, DmedSci, Prof., department of pediatrics.
197022, St-Petersburg, L.Tolstoy str., 6-8, (921) 420-49-31
N. N. Smirnova
Pavlov First Saint Petersburg State Medical University; Almazov National Medical Research Centre
Russian Federation
Russian Federation
Kuprienko Natalja B. - Senior lecturer, department of pediatrics.
197022, St-Petersburg, L.Tolstoy str., 6-8, 8-951-643-80-86
References
1. Raina R, Herrera N, Krishnappa V et al. Hematopoietic stem cell transplantation and acute kidney injury in children: a comprehensive review. Pediatr Transplant 2017 Jun; 21(4)
2. Arkan-Arikan A, Zappitelli M, Loftis LL et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 2007;71: 1028–1035
3. Lapes JA, Goncalves S, Jorge S et al. Contemporary analysis of the influence of acute kidney injury after reduce intensity conditioning hemopoietic cell transplantation on long term survival. Bone marrow Transplant 2008; 42(9): 619-626
4. Bunchman T. Stem cell transplantation and renal replacement therapy: new predictors of outcome. Pediatr Crit Care med 2010; 11: 754-755
5. Kizilbash S, Kashtan C, Chavers B et al. Acute kidney injury and the risk of mortality in children undergoing hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 2016; 22(7): 1264-1270
6. Sehgal B, George P, John MJ, Samuel C. Acute kidney injury and mortality in hematopoietic stem cell transplantation: a singlecenter experience. Indian J Nephrol 2017 Jan-Feb; 27(1): 13-19
7. Fadia A, Casserly LF, Sanchorawala V et al. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis. Kidney Int 2003; 63:1868-1873
8. Deirdre Sawinski The kidney effects of hematopoietic stem cell transplantation. Advances in chronic kidney disease 2014; 21, (1 Jan): 96-105
9. Cohen EP renal failure after bone marrow transplantation. Lancet 2001; 357 (9276): 6-7
10. Jones RJ, Lee KS, Beschorner WE et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44 (6): 778-783
11. Coppell JA, Richardson PG, Soiffer R et al. Hepatic venoocclusive disease following stem cell transplantation: incidence, clinical course, and outcome. Biol Blood Marrow Transplantation 2010; 16(2): 157-168
12. Mori J, Ohashi K, Yamaguchi T et al. Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria. Intern med 2012; 51:2105-2110
13. Ball LM, Egeler RM. Acute GvHD: pathogenesis and classification. Bone marrowTransplant 2008; 41(suppl2): S58-S64
14. Goldstein LS, Devarajan P. Progression from acute kidney injury to chronic kidney disease: a pediatric perspective. Adv Chronic Kidney Dis 2008; 15:278-283
15. Ellis MJ, Parikh CR, Inrig JK et al. Chronic kidney disease after hemapoietic cell transplantation: a systematic review. Am J Transplant 2008; 8: 2378-2390
16. Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012; 82: 516-524
17. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int 2006;69: 430–435
18. Robbins M, Bonsib S. Radiation nephropathy: a review. Scanning Microsc 1995;9:535-560
19. Cohen E, Piering W, Kabler-Babbitt C, Moulder J. Endstage renal disease (ESRD) after bone marrow transplantation: Poor survival compared to other causes of ESRD. Nephron 1998; 79: 408–412
20. Sangeeta Hingorani Chronic Kidney Disease in Long Term Survivors of Hematopoietic cell transplantation: Epidemiology, Pathogenesis and Treatment. J Am Soc Nephrol 2006; 17:1995-2005, Doi: 10.1681/ASN. 2006020118
21. Moake J. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589–599
22. Fuge R, Bird J, Frases A et al. The clinical features risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation. Br J Hematol 2001; 113:58-64
23. Ho V, Cutler C, Carter S et al. Blood and Marrow Transplant Clinical Trial Network Toxity Committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell trannsplatation. Biol Blood Marrow Transplant 2005;11:571-575
24. Chandler W, Jelacic S, Boster D et al. Prothrombotic coagulation abnormalities during Escherichia coli 0157:H7 infections. N Engl J Med 2002; 346:23-32
25. Rao P. Nephrotic syndrome in patients with peripheral blood stem cell transplant. Am J Kidney Dis 2005;45: 780–785
26. Miyazaki Y, Mori Y, Kishimoto N, et al. Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation. Int J Hematol 2003; 78: 262–265
27. Stylianou K, Stavros Stratakis S, Vasiliki Mavroeidi V et al. Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report. Journal of Medical Case Reports 2010; 4:303
28. Sakoda K, Shibuya A, Suzuki H et al. Nephrotic syndrome in patients after successful myeloablative allogeneic hematopoietic stem cell transplantation: clinical findings obtained from four trans-planted patients. Nihon Jinzo Gakkai Shi 2007;48 (8): 999-1006
29. Chanswangphuwana C, Townamchai N, Intraqumtornchai T, Bunworasate U. Glomerular diseases associated with chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation: case reports. DOI http://dx doi. Org/10.1016/I transproceed2014.07.076
30. Motoyama O, Uchino Y, Tokuyama M et al. A boy with membranous nephropathy after allogeneic bone marrow transplantation. Clin Exp Nephrol 2009; oct 13 (5): 508-511
Review
For citations:
Kuprienko N.B., Smirnova N.N. HEMATOPOIETIC STEM CELL TRANSPLANTATION AND NEPHROPATHY. Nephrology (Saint-Petersburg). 2018;22(1):52-57. (In Russ.) https://doi.org/10.24884/1561-6274-2018-22-1-52-57
Views:
1686
Email this article 